0
0
8/8/23 at 10:46pm
Organization
The Washington Post
Author
Leana S. Wen
35 words
0
Comments
The availability of zuranolone will prompt more mothers to be screened for postpartum depression and seek treatment options.
You are the first to view
https://www.washingtonpost.com/opinions/2023/08/08/postpartum-depression-pill-fda-approval/
Create an account
or login to join the discussion